氨茶碱与多索茶碱在支气管哮喘治疗中的应用价值分析

Analysis of applied value of aminophylline and doxophylline in the treatment of bronchial asthma

目的:探究氨茶碱与多索茶碱在支气管哮喘治疗中的临床应用价值。方法:2019年3月-2020年2月收治支气管哮喘患者150例,随机分为两组,各75例。A组给予氨茶碱治疗;B组给予多索茶碱治疗。比较两组患者肺功能指标水平及不良反应发生率。结果:B组治疗后肺功能指标水平显著优于A组,且不良反应发生率显著低于A组,差异均有统计学意义(P<0.05)。结论:对支气管哮喘患者进行药物治疗时应用多索茶碱,可以有效改善患者肺功能指标水平,降低用药后不良反应发生率。

Objective:To explore the clinical value of aminophylline and doxofylline in the treatment of bronchial asthma.Methods:From March 2019 to February 2020,150 cases of patients with bronchial asthma were enrolled,they were randomly divided into two groups with 75 cases in each group.A group was treated with aminophylline.B group was treated with doxophylline.The indicator levels of pulmonary function and the incidence of adverse reactions were compared between the two groups.Results:The indicator levels of pulmonary function of B group was significantly better than that of A group,while the incidence of adverse reactions was significantly lower than that of A group,the differences were statistically significant(P<0.05).Conclusion:The use of doxophylline in the treatment of bronchial asthma can effectively improve the indicator levels of pulmonary function and reduce the incidence of adverse reactions.